REVATIS REGENERATIVE MEDICINE AND CELL THERAPY
Live / Registered — Registered (as of 31 May 2022)
What this means for you
Registered since 31 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90553103
- Registration number
- 6742715
- Mark type
- Design + words
- Filed
- 01 Mar 2021
- Published for opposition
- 15 Mar 2022
- Registered
- 31 May 2022
- Attorney of record
- Nicholas D. Wells
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for regenerative medicine; orthopedic articles, namely, lubricating gel
- Class 010 — Medical apparatus: Medical apparatus and instruments for veterinary purposes and for use in surgery as it relates to regenerative medicine; cell culture apparatus for medical or veterinary use, namely, cell culture chambers; orthopedic articles, namely, bone prostheses, joint prostheses, medical instruments for use in performing biopsies in the nature of microbiopsies
- Class 040 — Treatment of materials: Cell cryopreservation services
- Class 042 — Scientific and technological services: Development of pharmaceutical products; development of cell therapy products; development of technologies for the manufacture and processing of cells for use in advanced cell therapy; Research and development of new products for others
- Class 044 — Medical, beauty and agricultural services: Veterinary services; Beauty and hygiene care services for animals; Skin care services being hygiene and beauty care; medical services
Owner
- REVATIS S.A., LIEGE, BE
- REVATIS S.A., LIEGE, BE
- REVATIS S.A., LIEGE, BE
Prior registrations
Prosecution history
- 31 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 15 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Mar 2022 — PUBLISHED FOR OPPOSITION
- 23 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Feb 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 08 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Feb 2022 — EXAMINER'S AMENDMENT ENTERED
- 08 Feb 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 08 Feb 2022 — EXAMINERS AMENDMENT E-MAILED
- 08 Feb 2022 — EXAMINERS AMENDMENT -WRITTEN
- 08 Feb 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Feb 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Feb 2022 — ASSIGNED TO LIE
- 28 Jan 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED